Nadolol 80mg tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Nadolol

Available from:

Neon Healthcare Ltd

ATC code:

C07AA12

INN (International Name):

Nadolol

Dosage:

80mg

Pharmaceutical form:

Oral tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 02040000; GTIN: 5060499391176

Patient Information leaflet

TAKE SPECIAL CARE WITH NADOLOL TABLETS
CHECK WITH YOUR DOCTOR OR PHARMACIST BEFORE TAKING
YOUR MEDICINE IF:
 You have any heart problems
 You have breathing problems due to long term
lung problems (called ‘bronchitis’ or ‘emphysema’)
 You have diabetes. Nadolol Tablets may cause low
blood sugar levels even in patients who are not
diabetic such as children, the elderly and those
who are fasting
 You have liver problems
 You have an overactive thyroid gland
 You have kidney problems
 You have a history of severe allergies
PACKAGE LEAFLET:
INFORMATION FOR THE USER
NADOLOL 80MG
TABLETS
Nadolol
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START
TAKING THIS MEDICINE.
•
Keep this leaflet. You may need to read it again
•
If you have any further questions, ask your doctor or
pharmacist
•
This medicine has been prescribed for you. Do not
pass it on to others. It may harm them, even if their
symptoms are the same as yours.
•
If any of the side effects get serious, or if you notice
any side effects not listed in this leaflet, please tell
your doctor or pharmacist.
IN THIS LEAFLET:
1. What Nadolol Tablets are and what they are used for
2. What you need to know before you take Nadolol Tablets
3. How to take Nadolol Tablets
4. Possible side effects
5. How to store Nadolol Tablets
6. Content of the pack and other information
1. WHAT NADOLOL TABLETS ARE AND WHAT THEY
ARE USED FOR
Nadolol Tablets contain a medicine called nadolol.
This belongs to a group of medicines called
beta-blockers. It works by slowing your heart rate or
lowering your blood pressure.
Nadolol Tablets are used for:
• Chest pain (angina)
• High blood pressure
• Uneven or unusually fast heart beats (arrhythmia)
• Symptoms of an overactive thyroid gland
• Stopping migraine attacks happening
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE
NADOLOL TABLETS
DO NOT TAKE NADOLOL TABLETS IF:
× You are allergic (hypersensitive) to nadolol or any
of the other ingredients of Nadolol Tablets (see
Section 6: Further information).
Sig

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Nadolol 80mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
_Active Substance: _
Nadolol 80.0mg.
For the full list of excipients, see section 6.1
3
PHARMACEUTICAL FORM
Tablet.
White or slightly mottled, capsule-shaped, biconvex tablet engraved
“80” on one side
and with a break line on the other side.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Nadolol is indicated in the management of:
Angina Pectoris:
For the long-term management of patients with angina pectoris by
continuous
medication.
Hypertension:
For the long-term management of essential hypertension, either alone
or in
combination with other antihypertensive agents, especially
thiazide-type diuretics.
Arrhythmias:
For the treatment of cardiac tachyarrhythmias.
Migraine:
For the prophylactic management of migraine headache. The efficacy of
Nadolol in
the treatment of a migraine attack that has already started has not
been established,
and Nadolol is not indicated for such use.
Thyrotoxicosis:
For the relief of the symptoms of hyperthyroidism and the pre-
operative preparation
of patients for surgery. Nadolol may be used in conjunction with
conventional
antithyroid therapy.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Adults:
Dosage should be titrated gradually with at least a week between
increments to assess
response; individuals show considerable variation in their response to
beta-adrenergic
blockade.
Nadolol may be given in a once daily dosage without regard to meals.
The dosage
interval should be increased when creatinine clearance is below
50ml/min/1.73m
2
.
If Nadolol is to be discontinued, reduce dosage over a period of at
least two weeks
(see warnings).
_Angina pectoris: _
Initially 40mg once daily. This may be increased at weekly intervals
until an adequate
response is obtained or excessive bradycardia occurs. Most patients
respond to
160mg or less daily. The value and safety of daily doses exceeding
240mg have not
been established.
_Hypertension: _
Initially 80mg once